Evidence map›Paper›PMID 28947980›Full record

ArticleOncotarget2017

Added value of diffusion weighted imaging in pediatric central nervous system embryonal tumors surveillance.

Giovanni Morana, Cesar Augusto Alves, Domenico Tortora, Mariasavina Severino, Paolo Nozza, Armando Cama, Marcello Ravegnani, Gabriella D'Apolito, Alessandro Raso, Claudia Milanaccio and 3 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. European Society for Paediatric Oncology (SIOPE) MRI guidelines for imaging patients with central nervous system tumours.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2021
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Giovanni Morana *Neuroradiology Unit, Istituto Giannina Gaslini, Genova, Italy.
Cesar Augusto Alves *Neuroradiology Unit, Istituto Giannina Gaslini, Genova, Italy.
Domenico TortoraNeuroradiology Unit, Istituto Giannina Gaslini, Genova, Italy.
Mariasavina SeverinoNeuroradiology Unit, Istituto Giannina Gaslini, Genova, Italy.
Paolo NozzaPathology Unit, Istituto Giannina Gaslini, Genova, Italy.
Armando CamaNeurosurgery Unit, Istituto Giannina Gaslini, Genova, Italy.
Marcello RavegnaniNeurosurgery Unit, Istituto Giannina Gaslini, Genova, Italy.
Gabriella D'ApolitoNeuroradiology Unit, Ospedale M. Bufalini, Cesena, Italy.
Alessandro RasoNeurosurgery Unit, Istituto Giannina Gaslini, Genova, Italy.
Claudia MilanaccioNeuro-Oncology Unit, Istituto Giannina Gaslini, Genova, Italy.
Claudia da Costa LeiteRadiology Institute, Hospital das Clinicas, Sao Paulo, Brazil.
Maria Luisa GarrèNeuro-Oncology Unit, Istituto Giannina Gaslini, Genova, Italy.
Andrea RossiNeuroradiology Unit, Istituto Giannina Gaslini, Genova, Italy.
Istituto Giannina Gaslini · ITHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BROspedale “M. Bufalini” di Cesena · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diffusion weighted imaging (DWI) has an established role in primary CNS embryonal tumor (ET) characterization; however, its diagnostic utility in detecting relapse has never been determined. We aimed to compare DWI and conventional MRI sensitivity in CNS ET recurrence detection, and to evaluate the DWI properties of contrast-enhancing radiation induced lesions (RIL). Fifty-six patients with CNS ET (25 with disease relapse, 6 with RIL and 25 with neither disease relapse nor RIL) were retrospectively evaluated with DWI, conventional MRI (including both T2/FLAIR and post-contrast images), or contrast-enhanced MR imaging (CE-MRI) alone. MRI studies were independently reviewed by two neuroradiologists for detection and localization of potential brain relapses. Sensitivity for focal relapse detection was calculated for each image set on a lesion-by-lesion basis. A descriptive per subject analysis was also performed. Evaluation of follow-up MRI studies served as standard of reference. Focal recurrence detection sensitivity of DWI (96%) was significantly higher than conventional MRI (77%) and CE-MRI alone (51%) (p=0.0003 and p<0.0001). On per subject analysis there were not missed diagnoses for DWI. At the time of DWI relapse detection, conventional MRI missed 2 diagnoses, and CE-MRI 8. Analysis of medulloblastoma relapses revealed that DWI identified a higher number of focal lesions than CE-MRI in subjects with classic variant. All but one RIL did not show restricted diffusion. In conclusion, DWI is a valuable complementary technique allowing for improved detection of focal relapse in CNS ET patients, particularly in children with classic medulloblastoma, and may assist in differentiating recurrence from RIL.

Indexed as

ATRTCNS embryonal tumorsDWImedulloblastomarelapse

Identifiers

PMID28947980
PMCPMC5601148
OpenAlexW2738609696

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.